About INVESCO MARKETS II

WH2E invests in stocks. The fund's major sectors are Health Technology, with 93.13% stocks, and Health Services, with 6.51% of the basket. The assets are mostly located in the North America region.

WH2E top holdings are Eli Lilly and Company and AbbVie, Inc., occupying 11.07% and 10.77% of the portfolio correspondingly.

WH2E assets under management is ‪83.88 M‬ CHF. It's fallen 1.06% over the last month.

WH2E fund flows account for ‪94.87 M‬ CHF (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.

No, WH2E doesn't pay dividends to its holders.

WH2E expense ratio is 0.18% meaning you'd have to pay 0.18% of your investment to help manage the fund.

WH2E follows the S&P Developed Ex-Korea LargeMidCap ESG Enhanced Health Care Index - Benchmark TR Net. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.

WH2E invests in stocks.

WH2E price has fallen by −2.14% over the last month, and its yearly performance shows a −18.23% decrease. See more dynamics on WH2E price chart.
NAV returns, another gauge of an ETF dynamics, have fallen by −0.42% over the last month, showed a −15.03% decrease in three-month performance and has decreased by −18.61% in a year.